Returns3 Years9.35%

Projections

Investment ofper month
gives returns of :
at 15.7% / annum
$in 10 years
amount
for a time period of
time1Y3Y5Y10Y
Returns % (CAGR)based on historic returns of 15.7% per annum
$
$
$+ 15.7%

Holdings

Last updated as on 27-1-2020

About IBB

Fund Asset Size(AUM) $i
Morningstar Ratings 2i
Symbol IBB
Exchange XNAS
ISIN US4642875565
Category Benchmark Index MSCI ACWI NR USD
Asset class Equity
Category Health
Country US

Portfolio Characteristics

Expense ratio 0.47i
Beta 1.35i
Standard Deviation 20.88i

Fund Strategy

iShares Nasdaq Biotechnology ETF is an exchange-traded fund incorporated in the USA. The Fund's objective seeks investment results that correspond to the performance of the Nasdaq Biotechnology Index. The Fund will concentrate its investments in companies primarily engaged in using biomedical research for the discovery or development of new treatments or cures for human disease.

About iShares by Blackrock

With more than twenty years of ETF experience, a global line-up of 800+ exchange-traded funds (ETFs) and $1.9 trillion in assets under management, iShares continually strives to unlock new opportunities for our investors. By channeling strategic thinking and expertise into a robust offering of investment funds, iShares aims to make wealth-building easier, more efficient, and more rewarding for all investors.

The Content is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice. Nothing contained in this page constitute a solicitation, recommendation, endorsement, or offer by Kristal.AI or any third party service provider to buy or sell any securities or other financial instruments in this or in in any other jurisdiction in which such solicitation or offer would be unlawful under the securities laws of such jurisdiction.

All Content on this page is information of a general nature and does not address the circumstances of any particular individual or entity. Nothing in this page constitutes professional and/or financial advice, nor does any information on the page constitute a comprehensive or complete statement of the matters discussed or the law relating thereto. You alone assume the sole responsibility of evaluating the merits and risks associated with the use of any information or other Content on this page before making any decisions based on such information or other Content.